Some members of the OPEN team had the chance to attend the 13th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD), which took place in Madrid from 19th until 22nd February.
Over the last decade, remarkable changes in the development and use of new technologies for people with diabetes (PwD) have been achieved. Main topics of this year’s conference were decision support systems, new CGM devices, open- and closed loop systems and automated insulin delivery (AID). OPEN met interesting people, kept up to date about the latest technological developments and experimented with new devices at the technology fair. The ATTD programme was simply overwhelming, so here is a selection of our personal highlights of the conference:
Due to an increasingly strict regulatory framework, it is becoming more and more difficult for independent patient advocates to attend conferences such as ATTD. For this reason, Bastian Hauck has created the #dedoc° voices programme, which provided 20 patient advocates with the opportunity to attend, network and keep up to date with the latest innovations in diabetes technology at the congress in Madrid, including the conference sessions and technology fair.
The participants of #dedoc° voices presented their ambitious projects, e.g. Paul Louis talked about his engagement in Madagascar and Jazz Sethi about her educational work for the Indian population with diabetes.
OPEN project manager Hanne Ballhausen and project coordinator Shane O´Donnell used the opportunity at #docday° to give a short introduction to the previous work and future objectives of the OPEN consortium.
If you got intrigued from these first insights, you will find the complete #docday° on video: https://dedoc.org/docday
2. JDRF Session
An Open-Protocol Automated Insulin Delivery Ecosystem Is Coming: What Does This Mean for People with Type-1-Diabetes?Read more OPEN at ATTD 2020